Repository

Publications

 

Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis

Akkus E, Yasar HA, Rimassa L, Lamarca A
Target Oncol. 2025 Apr 13. doi: 10.1007/s11523-025-01142-8
2025 

Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials

Yoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A
Journal of Hepatology. 2025 Mar 25. doi: 10.1016/j.jhep.2025.03.013
2025 

Deciphering the spatial tumor microenvironment in intrahepatic cholangiocarcinoma

Macias RIR, Roessler S, Verstegen MMA
Hepatology. 2025 Mar 24. doi: 10.1097/HEP.0000000000001322
2025 

Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, Krasnodębski M, Pertkiewicz J, Kozieł S, Grąt M, Raszeja-Wyszomirska J, Rullan M, Alkorta-Aranburu G, Oyón D, Fernández-Barrena M, Candels L, Białek A, Krupa Ł, Schneider K, Urman J, Strnad P, Trautwein C, Milkiewicz P, Krawczyk M, Ávila M, Berasain C
Liver Int . 2025 Apr;45(4):e70049. doi: 10.1111/liv.70049.
2025 
Join the Action
JOIN